Rapid emergence of atherosclerosis in Asia: A systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies

Current Opinion in Lipidology

Volumn 26, Issue 4, 2015, Pages 257-269

  Wong, Martin C S ^a   Zhang, De Xing ^a   Wang, Harry H X ^b,c  

^a Prince of Wales Hospital   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Asia; atherosclerosis; control; coronary heart disease; prevention

Indexed keywords

CHOLESTEROL;

AGING; ASIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; OBESITY; PHYSICAL INACTIVITY; PREVENTION AND CONTROL; PRIMARY PREVENTION; PRIORITY JOURNAL; REHABILITATION; REVIEW; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SODIUM INTAKE; SYSTEMATIC REVIEW; URBANIZATION; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE;

ASIA; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMANS;

EID: 84940741444     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000191     Document Type: Review

References (53)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-2128.
2. Gillespie CD, Wigington C, Hong Y; Centers for Disease Control and Prevention. Coronary heart disease and stroke deaths-United States, 2009. Morbidity and Mortality Weekly Report 2013; 62 (Suppl 3):157-160.
3. Allender S, Peto V, Scarborough P, et al. Coronary Heart Disease Statistics 2012. British Heart Foundation, London, UK; October 2012. ISBN 978-1-899088-12-6.
4. Nichols M, Townsend N, Scarborough P, Rayner M. European cardiovascular disease statistics 4th edition 2012: EuroHeart II. Eur Heart J 2013; 34:3007-3013.
5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II-variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104:2855-2864.
6. Wong MCS, Wang HHX, Cheung CSK, et al. Factors associated with multimorbidity and its link with poor blood pressure control among 223 286 hypertensive patients. Int J Cardiol 2014; 177:202-208.
7. Wang HHX, Wang JJ, Wong SYS, et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162 464 community household residents in southern China. BMC Med 2014; 12:188.
8. Moran A, Zhao D, Gu D, et al. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Public Health 2008; 8:394.
9. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies (March 2014). National Heart, Lung, and Blood Institute, Bethesda, MD, USA. Available at: https://www.nhlbi.nih.gov/health-pro/guidelines/indevelop/cardiovascular-risk-reduction/tools/cohort
10. World Health Organization (WHO). Global Health Estimates-Health Statistics and Information Systems. World Health Organization, Geneva, Switzerland; 2012.
11. Le C, Fang Y, Linxiong W, et al. Economic burden and cost determinants of coronary heart disease in rural southwest China: a multilevel analysis. Public Health 2015; 129:68-73.
12. Tang X, Laskowitz DT, He L, et al. Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. Int J Stroke 2015; 10:388-395.
13. Tian Z, Li S, Zhang J, Guo Y. The characteristic of heat wave effects on coronary heart disease mortality in Beijing, China: a time series study. Plos One 2013; 8:e77321.
14. Jiang G, Wang D, Li W, et al. Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition. Rev Panam Salud Publica 2012; 31:317-324.
15. Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. Circ J 2013; 77:1923-1932.
16. Nakamura K, Nakagawa H, Sakurai M, et al. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies. Cerebrovasc Dis 2012; 33:480-491.
17. Park GM, Yun SC, Cho YR, et al. Prevalence of coronary atherosclerosis in an Asian population: findings from coronary computed tomographic angiography. Int J Cardiovasc Imaging 2015; 31:659-668.
18. Sekhri T, Kanwar RS, Wilfred R, et al. Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ Open 2014; 4:e005346.
19. Meng Khoo C, Tai ES. Trends in the incidence and mortality of coronary heart disease in asian pacific region: the Singapore experience. J Atheroscler Thromb 2014; 21 (Suppl 1):S2-S8.
20. Khalili D, Sheikholeslami FH, Bakhtiyari M, et al. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PloS One 2014; 9: e105804.
21. Unal B, Sozmen K, Arik H, et al. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health 2013; 13:1135.
22. Rastam S, Al Ali R, Maziak W, et al. Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006. BMC Public Health 2012; 12:754.
23. Sy RG, Morales DD, Dans AL, et al. Prevalence of atherosclerosis-related risk factors and diseases in the Philippines. J Epidemiol 2012; 22:440-447.
24. Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011; 377:578-586.
25. Cheng J, Zhao D, Zeng Z, et al. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. BMC Public Health 2009; 9:30.
26. Baker P, Kay A, Walls H. Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature. Global Health 2014; 10:66.
27. Batcagan-Abueg AP, Lee JJ, Chan P, et al. Salt intakes and salt reduction initiatives in Asia: a review. Asia Pac J Clin Nutr 2013; 22:490-504.
28. Prabhakaran D, Jeemon P, Reddy KS. Commentary: poverty and cardiovascular disease in India: do we need more evidence for action? Int J Epidemiol 2013; 42:1431-1435.
29. Siegel KR, Patel SA, Ali MK. Noncommunicable diseases in South Asia: contemporary perspectives. Br Med Bull 2014; 111:31-44.
30. Zheng W, McLerran DF, Rolland BA, et al. Burden of total and cause-specific mortality related to tobacco smoking among adults aged-45 years in Asia: a pooled analysis of 21 cohorts. PLoS Med 2014; 11:e1001631.
31. Vathesatogkit P, Batty GD, Woodward M. Socioeconomic disadvantage and disease-specific mortality in Asia: systematic review with meta-analysis of population-based cohort studies. J Epidemiol Commun Health 2014; 68: 375-383.
32. Ohira T, Iso H. Cardiovascular disease epidemiology in Asia: an overview. Circ J 2013; 77:1646-1652.
33. Chen Y, Copeland WK, Vedanthan R, et al. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ 2013; 347:f5446.
34. Zoghbi WA, Duncan T, Antman E, et al. Sustainable Development Goals and the future of cardiovascular health: a statement from the global cardiovascular disease taskforce. J Am Heart Assoc 2014; 3:e000504.
35. Charlson FJ, Moran AE, Freedman G, et al. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med 2013; 11:250.
36. Ren Y, Yang H, Browning C, et al. Prevalence of depression in coronary heart disease in China: a systematic review and meta-analysis. Chin Med J (Engl) 2014; 127:2991-2998.
37. Hwang WJ, Hong OS, Rankin SH. Predictors of health-promoting behavior associated with cardiovascular diseases among Korean blue-collar workers. Asia Pac J Public Health 2015; 27:NP691-NP702.
38. Sakata Y, Shimokawa H. Epidemiology of heart failure in Asia. Circ J 2013; 77:2209-2217.
39. Ezzati M, Vander Hoorn S, Lawes CM, et al. Rethinking the 'diseases of affluence' paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2005; 2:e133.
40. Iqbal MP. Trans fatty acids: a risk factor for cardiovascular disease. Pak J Med Sci 2014; 30:194-197.
41. Wang HHX, Wang JJ, Lawson KD, et al. Relationships of multimorbidity and income with hospital admissions in 3 health care systems. Ann Fam Med 2015; 13:164-167.
42. Moser KA, Agrawal S, Davey Smith G, Ebrahim S. Socio-demographic inequalities in the prevalence, diagnosis and management of hypertension in India: analysis of nationally-representative survey data. Plos One 2014; 9:e86043.
43. Wang HHX, Wang JJ. Effects of community-based general practitioners-led care for 12 864 patients with hypertension: study of cardiovascular risk intervention-hypertension (SCRI-HTN) in China. Eur Heart J 2012; 33 (Suppl 1):762-763.
44. Sutton L, Karan A, Mahal A. Evidence for cost-effectiveness of lifestyle primary preventions for cardiovascular disease in the Asia-Pacific Region: a systematic review. Global Health 2014; 10:79.
45. Gupta R, Gupta N, KhedarRS. Smokeless tobacco and cardiovascular disease in low and middle income countries. Indian Heart J 2013; 65:369-377.
46. Lin PH, Yeh WT, Svetkey LP, et al. Dietary intakes consistent with the DASH dietary pattern reduce blood pressure increase with age and risk for stroke in a Chinese population. Asia Pac J Clin Nutr 2013; 22:482-491.
47. Wang HHX, Wong SYS, Wong MCS, et al. Patients' experiences in different models of community health centers in southern China. Ann Fam Med 2013; 11:517-526.
48. Yano Y, Briasoulis A, Bakris GL, et al. Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA). J Am Soc Hypertens 2014; 8:103-116.
49. Wang HHX, Wong MCS, Mok RY, et al. Factors associated with grade 1 hypertension: implications for hypertension care based on the Dietary Approaches to Stop Hypertension (DASH) in primary care settings. BMC Fam Pract 2015; 16:26.
50. Hong Kong Reference Framework for Preventive Care for Older Adults in Primary Care Settings. Hong Kong: Department of Health, The Government of Hong Kong Special Administrative Region; 2012.
51. Wong MCS, Tam WWS, Cheung CSK, et al. Drug adherence and the incidence of coronary heart disease-and stroke-specific mortality among 218 047 patients newly prescribed an antihypertensive medication: A fiveyear cohort study. Int J Cardiol 2013; 168:928-933.
52. Wong MCS, Tam WWS, Cheung CSK, et al. Medication adherence to firstline antihypertensive drug class in a large Chinese population. Int J Cardiol 2013; 167:1438-1442.
53. Sathe A, Flowers E, Mathur A, et al. A culturally specific health coaching program targeting cardiovascular disease risk in South Asians: rationale, design, and baseline data. Ethn Dis 2013; 23:304-309.